2028 Connected Drug Delivery Devices Market: Future Growth and Opportunities | Techsci Research

MANHATTAN, N.Y. - May 2, 2023 - PRLog -- According to a report by TechSci Research titled "Global Connected Drug Delivery Devices Market By Product Type, Technology, Application, End User, and Regional Distribution: Competition Forecast & Opportunities, 2028," the global market for connected drug delivery devices is anticipated to grow at a promising pace over the forecast period. The growth of the market is being driven by rising concerns over preventive care, a clear shift towards connected devices, and the efficiency of connected drug delivery devices. Government initiatives towards preventing chronic illnesses are also contributing to the market's growth over the next five years.

The COVID-19 pandemic and subsequent lockdowns have resulted in the shutdown of many manufacturing units and disruptions in the supply chain, leading to interrupted production and limited supply of implants worldwide. Furthermore, the pandemic has had a negative impact on the economy of many countries, hindering the growth of the connected drug delivery devices market. However, with the easing of lockdown restrictions, the market is expected to pick up pace once again.

The global connected drug delivery devices market is segmented based on product type, technology, application, end user, and regional distribution, with Bluetooth, near field communication, and other technologies being the main categories. In the past, the Bluetooth segment dominated the market, and it is expected to continue doing so over the next five years due to the increasing technological advancements in connected drug delivery devices and their compatibility with smartphones.

Some of the major competitors in the market include Abbott Laboratories, Inc., Reciprocal Labs Corporation (Propeller Health), F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Biocorp Production SA, Merck KGaA, Adherium Ltd, West Pharmaceutical Services, Inc., Aterica Digital Health, Molex LLC (Phillips Medisize), Cohero Health, Inc., Elcam Medical ACS. Ltd, Becton, Dickinson, and Company, Ypsomed Holding AG, and Unilife Corporation, among others. To remain competitive, companies are focusing on extensive research and development activities and forming alliances and partnerships.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Connected drug delivery devices Market"

https://www.techsciresearch.com/report/connected-drug-delivery-devices-market/7438.html

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7438